Gazelakis, Kathryn
Majeed, Ammar
Kemp, William
Di Muzio, Bruno
Gerstenmaier, Jan
Cheung, Wa
Roberts, Stuart K.
Article History
Received: 6 April 2021
Accepted: 11 October 2021
First Online: 25 October 2021
Competing interests
: Stuart Roberts declares that he received Consultancy Fees from Gilead and is a member of the Astra Zeneca, Eisai and Ipsen Australian HCC advisory Board. All other Authors have no conflicts of interest to declare.